CAS 182291-65-2

Linearmycin B

CAS: 182291-65-2

Linearmycin B, a polyene antibiotic from Streptomyces, causes B. subtilis lysis in Streptomyces Mg1 extract.

Fórmula: C₆₆H₁₀₃NO₁₆

Cor e Forma: Solid

Peso molecular: 1166.541

Ref: TM-T36049

Linearmycin B

CAS: 182291-65-2

Linearmycin B is an analog of tolvaptan that has been shown to have potent anticancer activity. It works as an inhibitor of kinases, which are enzymes that play a crucial role in the growth and survival of cancer cells. Linearmycin B has been found to induce apoptosis in human cancer cell lines, making it a promising candidate for the development of new anticancer drugs. In addition, Linearmycin B has been shown to be effective in inhibiting tumor growth in vivo. This compound may also have potential therapeutic applications beyond cancer treatment, as it has been shown to be a potent inhibitor of urine kinases and Chinese hamster ovary cell protein kinases. Overall, Linearmycin B represents a promising avenue for the development of novel kinase inhibitors with potential therapeutic applications in various diseases.

Fórmula: C₆₆H₁₀₃NO₁₆

Pureza: Min. 95%

Peso molecular: 1,166.5 g/mol

Ref: 3D-HHA29165